Patents by Inventor Herve Bouchard

Herve Bouchard has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20040248884
    Abstract: The present invention relates to a cyclic urea compound of formula I: 1
    Type: Application
    Filed: February 2, 2004
    Publication date: December 9, 2004
    Applicant: AVENTIS PHARMA S.A.
    Inventors: Marcel Patek, Anil Nair, Augustin Hittinger, Conception Nemecek, Daniel Bond, Greg Harlow, Herve Bouchard, Jacques Mauger, Jean-Luc Malleron, Mark Palermo, Fahad Al-Obeidi, Thomas Faitg, Hartmut Strobel, Sven Ruf, Kurt Ritter, Youssef El-Ahmad, Dominique Lesuisse
  • Publication number: 20040242559
    Abstract: The invention relates to compounds of formula (I): 1
    Type: Application
    Filed: April 23, 2004
    Publication date: December 2, 2004
    Applicant: Aventis Pharma S.A.
    Inventors: Antonio Ugolini, Herve Bouchard
  • Publication number: 20040235816
    Abstract: Disclosed are azetidine derivatives of formula: 1
    Type: Application
    Filed: June 17, 2004
    Publication date: November 25, 2004
    Applicant: Aventis Pharma S.A.
    Inventors: Daniel Achard, Herve Bouchard, Jean Bouquerel, Marc Capet, Serg Grisoni, Jean-Luc Malleron, Serg Mignani, Augustin Hittinger
  • Patent number: 6818637
    Abstract: The invention concerns novel derivatives of formula (I) wherein: R1 represents the stereoisomeric forms of the chain —(CHOH)3—CH2—O—COR (II) and either R2 represents a hydrogen atom and R3 represents the stereoisomeric forms of the chain —CH2—(CHOH)2—CH2—O—COR (III) or R2 represents the stereoisomeric forms of the chains —(CHOH)3—CH2—O—COR (II) or —CH2—(CHOH)2—CH2—O—COR (III) and R3 represents a hydrogen atom and R represents —(Alk)1—(Cycloalk) radical; i is equal to 0 or 1; Alk represents and alkyl radical, Cycloalk represents a cycloalkyl radical, and their salts with a inorganic or organic acid, their preparation and the medicines containing as active principle at least a product of general formula (I) or its salts with a inorganic or organic acid.
    Type: Grant
    Filed: July 11, 2001
    Date of Patent: November 16, 2004
    Assignee: Aventis Pharma SA
    Inventors: Herve Bouchard, Alain Commercon
  • Patent number: 6815437
    Abstract: Group A streptogramin derivatives of formula (I): the salts thereof, and mixtures of stereoisomers thereof, as well as processes for preparing them and pharmaceutical compositions comprising them are disclosed.
    Type: Grant
    Filed: January 27, 2000
    Date of Patent: November 9, 2004
    Assignee: Aventis Pharma S.A.
    Inventors: Alain Commerçon, Hervé Bouchard, Yves Ribeill, Eric Bacque, Baptiste Ronan, Jean-Claude Barriere, Gérard Puchault, Corinne Terrier
  • Publication number: 20040157823
    Abstract: The present invention relates to pharmaceutical compositions containing, as active ingredient, a compound of formula: 1
    Type: Application
    Filed: February 4, 2004
    Publication date: August 12, 2004
    Applicant: Aventis Pharma S.A.
    Inventors: Daniel Achard, Herve Bouchard, Jean Bouquerel, Bruno Filoche, Serge Grisoni, Augustin Hittinger, Michael R. Myers
  • Publication number: 20040138257
    Abstract: The present invention relates to cancer therapy and to novel anticancer agents having a mechanism of action which is quite specific. It also relates to novel chemical compounds as well as their therapeutic application in humans.
    Type: Application
    Filed: November 25, 2003
    Publication date: July 15, 2004
    Applicant: Aventis Pharma S.A.
    Inventors: Herve Bouchard, Augustin Hittinger
  • Patent number: 6734176
    Abstract: The present invention relates to pharmaceutical compositions containing, as active ingredient, a compound of formula: in which R1 represents a radical —NHCOR4 or —N(R5)—Y—R6, Y is CO or SO2, R4 represents a radical -alk-SO2—R11, -alk-SO2—CH═CH—R11 or Het substituted with —SO2—R11 or a phenyl radical substituted with —SO2—R11 or -alk-SO2—R11, R5 represents a hydrogen atom or an alkyl radical, R6 represents a phenylalkyl, Het or Ar radical, to the novel derivatives of formula (I) and to their preparation, as well s to their use in treating various disorders of the nervous system.
    Type: Grant
    Filed: December 17, 2002
    Date of Patent: May 11, 2004
    Assignee: Aventis Pharma S.A.
    Inventors: Daniel Achard, Hervé Bouchard, Jean Bouquerel, Bruno Filoche, Serge Grisoni, Augustin Hittinger, Michael R. Myers
  • Publication number: 20040053931
    Abstract: The invention is directed to physiologically active compounds of general formula (I):— 1
    Type: Application
    Filed: June 21, 2002
    Publication date: March 18, 2004
    Inventors: Paul J. Cox, Tahir N. Majid, Justine Yeun Quai Lai, Andrew D. Morley, Shelley Amendola, Stephanie D. Deprets, Christopher Edlin, Charles J. Gardner, Dorothea Kominos, Brian L. Pedgrift, Frank Halley, Timothy A. Gillespy, Michael Edwards, Francois F. Clerc, Conception Nemecek, Olivier Houille, Dominique Damour, Herve Bouchard, Daniel N.A. Bezard, Chantal Carrez
  • Publication number: 20040048868
    Abstract: The invention is directed to physiologically active compounds of the general formula (Ix) 1
    Type: Application
    Filed: October 24, 2002
    Publication date: March 11, 2004
    Inventors: Michael L. Edwards, Paul J. Cox, Shelley Amendola, Stephanie D. Deprets, Timothy A. Gillespy, Christopher D. Edlin, Andrew D. Morley, Charles J. Gardner, Brian Pedgrift, Herve Bouchard, Didier Babin, Laurence Gauzy, Alain Le-Brun, Tahir N. Majid, John C. Reader, Lloyd J. Payne, Nawaz M. Khan, Michael Cherry
  • Publication number: 20030162808
    Abstract: Disclosed are azetidine derivatives of formula: 1
    Type: Application
    Filed: December 16, 2002
    Publication date: August 28, 2003
    Inventors: Daniel Achard, Herve Bouchard, Jean Bouquerel, Marc Capet, Serg Grisoni, Jean-Luc Malleron, Serge Mignani, Augustin Hittinger
  • Patent number: 6593482
    Abstract: Methods of preparing methylthiomethyloxy taxoids of formula (XXXIV) from baccatin and &bgr;-lactam are presented. These new taxoids display noteworthy anti-tumor and anti-leukemic properties.
    Type: Grant
    Filed: December 31, 2001
    Date of Patent: July 15, 2003
    Assignees: Aventis Pharma S.A., The Research Foundation of State University of New York
    Inventors: Hervé Bouchard, Jean-Dominique Bourzat, Alain Commerçon, Iwao Ojima
  • Publication number: 20030119810
    Abstract: The present invention relates to pharmaceutical compositions containing, as active ingredient, a compound of formula: 1
    Type: Application
    Filed: December 17, 2002
    Publication date: June 26, 2003
    Inventors: Daniel Achard, Herve Bouchard, Jean Bouquerel, Bruno Filoche, Serge Grisoni, Augustin Hittinger, Michael R. Myers
  • Patent number: 6566356
    Abstract: The present invention relates to pharmaceutical compositions containing, as active ingredient, a compound of formula: in which R1 represents a radical —NHCOR4 or —N(R5)—Y—R6, Y is CO or SO2, R4 represents a radical -alk-SO2—R11, -alk-SO2—CH═CH—R11 or Het substituted with —SO2—R11 or a phenyl radical substituted with —SO2—R11 or -alk-SO2—R11, R5 represents a hydrogen atom or an alkyl radical, R6 represents a phenylalkyl, Het or Ar radical, to the novel derivatives of formula (I) and to their preparation.
    Type: Grant
    Filed: March 2, 2001
    Date of Patent: May 20, 2003
    Assignee: Aventis Pharma S.A.
    Inventors: Daniel Achard, Hervé Bouchard, Jean Bouquerel, Bruno Filoche, Serge Grisoni, Augustin Hittinger, Michael R. Myers
  • Publication number: 20030083497
    Abstract: New taxoids of general formula (I), their preparation, and pharmaceutical compounds containing them.
    Type: Application
    Filed: March 13, 2002
    Publication date: May 1, 2003
    Applicant: Aventis Pharma, S.A.
    Inventors: Herve Bouchard, Jean-Dominique Bourzat, Alain Commercon
  • Publication number: 20030055033
    Abstract: Compounds of formula: 1
    Type: Application
    Filed: September 12, 2002
    Publication date: March 20, 2003
    Inventors: Daniel Achard, Herve Bouchard, Jean Bouquerel, Bruno Filoche, Serge Grisoni, Augustin Hittinger, Michael R. Myers
  • Patent number: 6518264
    Abstract: Disclosed are azetidine derivatives of formula: their optical isomers, their salts, their preparation and medicaments containing them.
    Type: Grant
    Filed: March 9, 2001
    Date of Patent: February 11, 2003
    Assignee: Aventis Pharma S.A.
    Inventors: Daniel Achard, Hervé Bouchard, Jean Bouquerel, Marc Capet, Serg Grisoni, Jean-Luc Malleron, Serge Mignani, Augustin Hittinger
  • Patent number: 6479479
    Abstract: Compounds of formula: in which R represents a CR1R2, C═C(R5)SO2R6 or C═C(R7)SO2alk radical, their preparation and the pharmaceutical compositions containing them.
    Type: Grant
    Filed: March 2, 2001
    Date of Patent: November 12, 2002
    Assignee: Aventis Pharma S.A.
    Inventors: Daniel Achard, Hervé Bouchard, Jean Bouquerel, Bruno Filoche, Serge Grisoni, Augustin Hittinger, Michael R. Myers
  • Publication number: 20020087013
    Abstract: Methods of preparing methylthiomethyloxy taxoids of formula (XXXIV) 1
    Type: Application
    Filed: December 31, 2001
    Publication date: July 4, 2002
    Applicant: Aventis Pharma S.A.
    Inventors: Herve Bouchard, Jean-Dominique Bourzat, Alain Commercon, Iwao Ojima
  • Publication number: 20020077324
    Abstract: The invention concerns novel derivatives of 1
    Type: Application
    Filed: July 11, 2001
    Publication date: June 20, 2002
    Inventors: Herve Bouchard, Alain Commercon